KCM
MDT icon

Kennedy Capital Management’s Medtronic MDT Stock Holding History

Kennedy Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Sell
23,297
-1,247
-5% -$101K 0.03% 462
2026
Q1 		$2.13M Sell
24,544
-1,074
-4% -$103K 0.05% 413
2025
Q4 		$2.46M Sell
25,618
-172
-0.7% -$16.7K 0.05% 400
2025
Q3 		$2.46M Buy
+25,790
New +$2.37M 0.05% 417

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Kennedy Capital Management's MDT Position: Q2 2026 in Review

Kennedy Capital Management reduced its Medtronic (MDT) stake by 5.1% in Q2 2026, selling an estimated $101K and leaving 23,297 shares worth $1.82M. The position accounts for 0.03% of the portfolio, ranked #462.

Kennedy Capital Management first reported a position in MDT in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.46M in Q4 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Kennedy Capital Management held 23,297 shares of Medtronic worth $1.82M as of Q2 2026.
  • Kennedy Capital Management sold 1,247 Medtronic shares in Q2 2026, an estimated $101K.
  • Medtronic made up 0.03% of Kennedy Capital Management's portfolio in Q2 2026, its #462 holding.
  • Kennedy Capital Management first reported a position in Medtronic in Q3 2025 and has held it in 4 quarters since.
  • Kennedy Capital Management's Medtronic position peaked at $2.46M in Q4 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.